Vascular disrupting agent for neovascular age related macular degeneration: a pilot study of the safety and efficacy of intravenous combretastatin a-4 phosphate

Overview of attention for article published in BMC Pharmacology and Toxicology, January 2013

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 313 followers.

Vascular disrupting agent for neovascular age related macular degeneration: a pilot study of the safety and effi... http://t.co/GfMHM7Mi

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.